Helicobacter pylori (H. pylori) is an extremely common, yet underappreciated, pathogen that
is able to alter host physiology and subvert the host immune response, allowing it to persist …

With few exceptions, the most commonly recommended triple Helicobacter pylori regimen
(proton pump inhibitor (PPI), amoxicillin and clarithromycin) now provides unacceptably low …

Helicobacter pylori (H. pylori) remains a prevalent, worldwide, chronic infection. Though the
prevalence of this infection appears to be decreasing in many parts of the world, H. pylori …

Abstract Background and Aims. Prevalence of H. pylori antibiotic resistance is increasing
worldwide, and it is the main factor affecting efficacy of current therapeutic regimens. Our …

The K orean C ollege of H elicobacter and U pper G astrointestinal R esearch first
developed guidelines for the diagnosis and treatment of H elicobacter pylori (H. pylori) …

Background Whether sequential treatment can replace triple therapy as the standard
treatment for Helicobacter pylori infection is unknown. We compared the efficacy of …

Background: Antimicrobial resistance has decreased eradication rates for Helicobacter
pylori infection worldwide. Objective: To determine whether sequential treatment eradicates …

Helicobacter pylori infection can be diagnosed by invasive techniques requiring endoscopy
and biopsy (eg histological examination, culture and rapid urease test) and by non-invasive …

OBJECTIVES: Eradication rates with triple therapy (TT) forHelicobacter pyloriinfection have
declined to unacceptable levels. Sequential therapy (ST) is a novel treatment that has …

Background: Standard proton-pump inhibitor–based therapy for Helicobacter pylori infection
fails in up to one quarter of patients. Sequential therapy may be more efficacious. Purpose …